Compare stocks
Add stockDates End of financial period
| #1 | #2 | #3 | #4 | #5 | #6 | #7 | #8 | |
|---|---|---|---|---|---|---|---|---|
| Remove Horton D R Inc | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
| Remove Regeneron Pharm... | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
| Remove Stryker Corp | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 |
Profit ROIC / ROE/ROA / ROE / ROA
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| Horton D R Inc (ROE/ROA) | 65.2% | 69.0% | 70.9% | 72.6% |
| Regeneron Pharmaceut... (ROE/ROA) | 68.9% | 71.2% | 71.6% | 73.4% |
| Stryker Corp (ROIC) | 10.7% | 10.0% | 10.8% | 10.6% |
Growth Sales and OCF growth / Sales and net income growth
| #1 | #2 | #3 | #4 | |
|---|---|---|---|---|
| Horton D R Inc | 3.5% | 6.2% | 2.5% | 13.4% |
| Regeneron Pharmaceut... | 5.0% | 13.0% | 5.3% | 8.8% |
| Stryker Corp | 11.0% | 14.3% | 13.6% | 15.7% |
Payout Shareholder distributions / net income
| #1 | #2 | #3 | #4 | #5 | |
|---|---|---|---|---|---|
| Horton D R Inc | 114% | 111% | 103% | 99% | 88% |
| Regeneron Pharmaceut... | 72% | 62% | 56% | 57% | 54% |
| Stryker Corp | 37% | 40% | 40% | 39% | 40% |
Safety Equity/assets and OCF stability / Equity/assets and net income stability
| Balance | Stability | |
|---|---|---|
| Horton D R Inc | 65.5% | 65.3% |
| Regeneron Pharmaceut... | 76.8% | 91.6% |
| Stryker Corp | 48.6% | 86.6% |
Price Earnings and FCF yield / Earnings and book yield
| Earnings | FCF / Book | |
|---|---|---|
| Horton D R Inc | $7.78 | $8.16 |
| Regeneron Pharmaceut... | $5.33 | $4.63 |
| Stryker Corp | $3.47 | $4.38 |
